Stock Price & Analysis

The S1 support level for NAYA Stock is $0.35 ,The R1 resistant level for NAYA Stock is $0.41.

As of the end of day on 2025-03-03, the price of NAYA Stock was $0.374.

The target price for NAYA Stock according to analyst rating is 2.00, with the highest price target at 2.00 and the lowest at 2.00. Analysts have a Moderate Buy rating on NAYA Stock overall.

The market cap of NAYA is $2.6M.

NAYA Biosciences, Inc. formerly INVO Bioscience, Inc. operates the fertility business, as well as its focus to the development of clinical-stage assets in oncology and autoimmune diseases. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. It offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.

NAYA has a total of 25 employees.